Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,041,216
-$2,146,231 QoQ
Shares Held
248,173
-39.5% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 317 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Derivatives in VCEL
reported options exposure · as of Jun 30, 2026CallValue
$409,308
CallShares
9,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. VCEL ranks #23 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in VCEL
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $409,308 | 9,200 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $11,041,216 | 248,173 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,187,447 | 409,930 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $558,155 | 15,500 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $2,091,653 | 66,465 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $536,130 | 12,600 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $1,082,812 | 25,448 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,508,559 | 78,632 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $539,902 | 12,100 | Call | Defined | 2025-05-19 | |
| 2024-12-31 | $549,100 | 10,000 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $2,970,466 | 54,097 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $249,275 | 5,900 | Call | Defined | 2024-11-15 | |
| 2024-09-30 | $4,397,971 | 104,094 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $3,443,614 | 75,057 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $529,875 | 10,186 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $299,408 | 8,408 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $332,417 | 9,917 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,713,267 | 45,602 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,050,318 | 69,929 | Shares | Defined | 2023-05-16 | |
| 2022-03-31 | $280,687 | 7,344 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $526,620 | 13,400 | Put | Defined | 2022-02-15 | |
| 2021-12-31 | $292,588 | 7,445 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $366,000 | 7,500 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $1,100,610 | 20,964 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $966,000 | 18,400 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $286,749 | 5,162 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $1,178,318 | 38,158 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $422,206 | 22,785 | Shares | Defined | 2020-11-17 | |
| 2020-06-30 | $285,285 | 20,643 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $104,272 | 11,371 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||